Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
CC transcript
Inv. presentation
Acq. announced
Director departure
Appointed director
METLIFE INC (MET) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Amended and Restated By-Laws of MetLife, Inc., effective as of October 3, 2023, redlined for amendments effective as of October 3, 2023",
"Amended and Restated By-Laws of MetLife, Inc., effective as of October 3, 2023"
10/05/2023 8-K/A Submission of Matters to a Vote of Security Holders  Interactive Data
08/15/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549",
"METLIFE DECLARES THIRD QUARTER 2023 PREFERRED STOCK DIVIDENDS"
08/10/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/09/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 8-K Quarterly results
Docs: "METLIFE ANNOUNCES SECOND QUARTER 2023 RESULTS",
"Assets Under Management June 30, 2023 Investors",
"221 2Q22 3Q22 4Q22 1Q23 2Q23 2Q23 VII"
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/13/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/12/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/12/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
07/12/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Even...
Docs: "Underwriting Agreement, among the Company and Barclays Capital Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named in Schedule I to the Pricing Agreement",
"Pricing Agreement, among the Company and Barclays Capital Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein",
"Thirty-Eighth Supplemental Indenture, between the Company and the Trustee",
"Opinion Letter of Willkie Farr & Gallagher LLP relating to the validity of the Senior Notes"
07/11/2023 424B2 Form 424B2 - Prospectus [Rule 424(b)(2)]:
07/10/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
07/10/2023 424B2 Form 424B2 - Prospectus [Rule 424(b)(2)]:
06/28/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
06/28/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
06/28/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
06/28/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
06/28/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
06/28/2023 13F-HR/A Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]
05/25/2023 8-K Investor presentation
Docs: "METLIFE ANNOUNCES $19.2 BILLION RISK TRANSFER TRANSACTION; FURTHER INCREASES SHARE REPURCHASE AUTHORIZATION TO $4 BILLION",
"Slide presentation to be presented at MetLife, Inc.’s investor conference on May 25, 2023"
05/15/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/09/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549",
"Amended and Restated Credit Agreement, among MetLife, Inc. and MetLife Funding, Inc., as borrowers, and the other parties signatory thereto"
05/04/2023 SC 13D/A BOARD OF DIRECTORS OF METLIFE INC reports a 15.9% stake in MetLife, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy